GOSS Stock Analysis: Buy, Sell, or Hold?
GOSS - Gossamer Bio, Inc. Common Stock
$0.17
0.00 (2.42%)
β²
5d:
-12.94%
30d:
+0.23%
90d:
-53.06%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When GOSS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: GOSS is down 12.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: GOSS is down 12.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GOSS is currently trading at $0.17, which is considered fair relative to its 30-day fair value range of $0.15 to $0.19.
Technical Outlook: Technically, GOSS is in a strong uptrend. Immediate support is located at $0.13, while resistance sits at $0.27.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.86 (+2121.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GOSS is in a strong uptrend. Immediate support is located at $0.13, while resistance sits at $0.27.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.86 (+2121.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.15 -
$0.19
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding GOSS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2121.2% below Wall St target ($3.86)
- WARNING: Recommendation downgraded due to -12.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.15 -
$0.19
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$0.27
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.85
Wall Street Target
$3.86
(+2121.2%)
Revenue Growth (YoY)
71.5%
Share & Embed Analysis
Last updated: August 03, 2026 7:36 PM ET
Data refreshes hourly during market hours. Next update: 8:36 PM
Data refreshes hourly during market hours. Next update: 8:36 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GOSS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical⦠|
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut⦠|
STRONG BUY
16 analysts |
$28 | 56 HOLD |
|
ACAD
ACADIA Pharmaceuticals I⦠|
BUY
20 analysts |
$33 | 58 HOLD |
Advanced GOSS Option Strategies
Professional options setups generated by AI based on today's GOSS price and gamma walls.